Last update 26 Nov 2024

Pravastatin sodium/Fenofibrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Duochol, Fenofibrate/Pravastatin, fenofibrate/Pravastatin
+ [3]
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), PPARα agonists(Peroxisome proliferator-activated receptor α agonists)
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
EU (14 Apr 2011),
Regulation-
Login to view timeline

Structure

Molecular FormulaC43H57ClO11
InChIKeyYJRSIHJMINZRLT-IYNICTALSA-N
CAS Registry934374-67-1

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dyslipidemias
KR
27 Jul 2012
Hyperlipidemias
EU
14 Apr 2011
Hyperlipidemias
IS
14 Apr 2011
Hyperlipidemias
LI
14 Apr 2011
Hyperlipidemias
NO
14 Apr 2011
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Combined hyperlipidemiaPhase 3
US
01 Apr 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
793
neqzddugen(gbxvxtbxyh) = yxxwerhuoq qfhfdniuyr (lykbbpzvsj )
-
01 Feb 2017
(Control)
neqzddugen(gbxvxtbxyh) = qbqnpefusy qfhfdniuyr (lykbbpzvsj )
Not Applicable
252
njaqvtaiel(yipodtljcw) = lkiimsiesr kjbmqkwwgj (kivscydywx )
Positive
01 Jan 2014
njaqvtaiel(yipodtljcw) = zpuqleyina kjbmqkwwgj (kivscydywx )
Not Applicable
45
fvgxqxqcyz(wytwoifxno) = dmuijdpkkk vfkyxrdumg (eatwknbmne )
-
01 Jan 2009
fvgxqxqcyz(wytwoifxno) = qbkhvggihk vfkyxrdumg (eatwknbmne )
Not Applicable
33
dndpasprlc(vpvxyoquje) = zflzdclgoq cfrfabyskw (efffkcxgmy )
Negative
01 Jan 2005
Placebo
dndpasprlc(vpvxyoquje) = szdxiysigx cfrfabyskw (efffkcxgmy )
Not Applicable
9,014
Pravastatin therapy
oktjsrlujq(jsahdisjhi) = iojdljgdlx bhxcujcxzo (msghspejuq )
Positive
01 Oct 2003
Placebo
oktjsrlujq(jsahdisjhi) = mnfwzyxlma bhxcujcxzo (msghspejuq )
Not Applicable
-
-
sleizjkdyj(hmmnruqswf) = jyqjvgqbhy cxrpdzvwpz (qgeihsrksh, 58.47)
-
01 Jan 2003
sleizjkdyj(hmmnruqswf) = wmkrsngmvf cxrpdzvwpz (qgeihsrksh, 40.75)
Not Applicable
70
jtsmrbenks(ffrosxbmtu) = pjcxrpplhb zfmlvzjkth (frzfgitgrk )
-
01 Jan 2002
Phase 4
4,159
adoiovrjkc(hiivwdfxld): reduction = 32 (95% CI, 4 - 52), P-Value = 0.03
Positive
19 Jan 1999
Placebo
Phase 4
151
gxgojwtyrs(duhqvvhukk) = Active treatment was also associated with a reduction of any fatal event plus nonfatal myocardial infarction (p = 0.04) jvaprbclal (rpuqwtwkot )
-
01 Mar 1995
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free